These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22453843)

  • 41. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
    Lund Laursen T; Brøckner Siggard C; Kazankov K; Damgaard Sandahl T; Møller HJ; Ong A; Douglas MW; George J; Tarp B; Hagelskjaer Kristensen L; Lund Laursen A; Hiramatsu A; Nakahara T; Chayama K; Grønbaek H
    Scand J Gastroenterol; 2018 Aug; 53(8):986-993. PubMed ID: 29987961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction.
    Kračmerová J; Rossmeislová L; Kováčová Z; Klimčáková E; Polák J; Tencerová M; Mališová L; Štich V; Langin D; Šiklová M
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E528-35. PubMed ID: 24423341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased serum levels of macrophage activation marker sCD163 in Dengue patients.
    S S SG; Pillai AB; Ramachandrappa VS; T K; Dhodapkar R; Kah J; Rajendiran S
    J Clin Virol; 2017 Jan; 86():62-67. PubMed ID: 27960133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.
    Møller HJ; Nielsen MJ; Maniecki MB; Madsen M; Moestrup SK
    Immunobiology; 2010 May; 215(5):406-12. PubMed ID: 19581020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.
    Higashi-Kuwata N; Jinnin M; Makino T; Fukushima S; Inoue Y; Muchemwa FC; Yonemura Y; Komohara Y; Takeya M; Mitsuya H; Ihn H
    Arthritis Res Ther; 2010; 12(4):R128. PubMed ID: 20602758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased levels of soluble CD163 in periodontitis patients.
    Detzen L; Chen SCY; Cheng B; Papapanou PN; Lalla E
    J Clin Periodontol; 2017 Jun; 44(6):585-590. PubMed ID: 28419494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of serum CD163 as a marker of fibrosis in patients with NAFLD.
    Ragab HM; El Maksoud NA; Amin MA; Elaziz WA
    Diabetes Metab Syndr; 2021; 15(1):87-92. PubMed ID: 33310266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis].
    Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.
    Nunes PR; Romão-Veiga M; Peraçoli JC; Araujo Costa RA; de Oliveira LG; Borges VTM; Peraçoli MT
    Immunol Res; 2019 Jun; 67(2-3):194-201. PubMed ID: 31240481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.
    Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Møller HJ; Hokland M; Kuppen PJK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble CD163 from activated macrophages predicts mortality in acute liver failure.
    Møller HJ; Grønbaek H; Schiødt FV; Holland-Fischer P; Schilsky M; Munoz S; Hassanein T; Lee WM;
    J Hepatol; 2007 Nov; 47(5):671-6. PubMed ID: 17629586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
    Tantawy AA; Adly AA; Ismail EA
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure.
    Ptaszynska-Kopczynska K; Marcinkiewicz-Siemion M; Lisowska A; Waszkiewicz E; Witkowski M; Jasiewicz M; Miklasz P; Jakim P; Galar B; Musial WJ; Kaminski KA
    Cytokine; 2016 Apr; 80():7-12. PubMed ID: 26916171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.
    Fjeldborg K; Christiansen T; Bennetzen M; J Møller H; Pedersen SB; Richelsen B
    Obesity (Silver Spring); 2013 Dec; 21(12):2437-43. PubMed ID: 23512476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage-derived soluble CD163 level in young patients with Gaucher disease: relation to phenotypes, disease severity and complications.
    Adly AAM; Ismail EAR; Ibraheem TM
    Int Immunopharmacol; 2015 Feb; 24(2):416-422. PubMed ID: 25587690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis.
    Aristoteli LP; Møller HJ; Bailey B; Moestrup SK; Kritharides L
    Atherosclerosis; 2006 Feb; 184(2):342-7. PubMed ID: 15979079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and application of a porcine specific ELISA for the quantification of soluble CD163.
    Pasternak JA; MacPhee DJ; Harding JCS
    Vet Immunol Immunopathol; 2019 Apr; 210():60-67. PubMed ID: 30947982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
    Zanni MV; Burdo TH; Makimura H; Williams KC; Grinspoon SK
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):385-90. PubMed ID: 22098563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
    Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
    Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.